Evidence map›Paper›PMID 28613348›Full record

ArticleJournal of biomedical optics2017

Multimodal fluorescence molecular imaging for in vivo characterization of skin cancer using endogenous and exogenous fluorophores.

Jessica P Miller, LeMoyne Habimana-Griffin, Tracy S Edwards, Samuel Achilefu

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Optical and Photoacoustic Imaging.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Multispectral autofluorescence dermoscope for skin lesion assessment.Photodiagnosis and photodynamic therapy · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jessica P MillerWashington University School of Medicine, Mallinckrodt Institute of Radiology, Optical Radiology Laboratory, St. Louis, Missouri, United StatesbWashington University in St. Louis, Biomedical Engineering, St. Louis, Missouri, United States.
LeMoyne Habimana-GriffinWashington University School of Medicine, Mallinckrodt Institute of Radiology, Optical Radiology Laboratory, St. Louis, Missouri, United StatesbWashington University in St. Louis, Biomedical Engineering, St. Louis, Missouri, United States.
Tracy S EdwardsWashington University School of Medicine, Mallinckrodt Institute of Radiology, Optical Radiology Laboratory, St. Louis, Missouri, United States.
Samuel AchilefuWashington University School of Medicine, Mallinckrodt Institute of Radiology, Optical Radiology Laboratory, St. Louis, Missouri, United StatesbWashington University in St. Louis, Biomedical Engineering, St. Louis, Missouri, United States.

Funding

WU-MDACC Inter-Institutional Molecular Imaging CenterP50CA094056 · NCI · WASHINGTON UNIVERSITY · PI KOPAN, RAPHAEL · 2002 to 2016
$26.3M
Project 2 - Radiation-Induced Treatment of Multiple Myeloma using NanoparticlesU54CA199092 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2019
$11.5M
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERYR01CA171651 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2013 to 2017
$2.8M
MOLECULAR PROBES AND METHODS FOR FLUORESCENCE LIFETIME TOMOGRAPHY AND MICROSCOPYR01EB008111 · NIBIB · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2009 to 2012
$1.9M
NEAR INFRARED PH-SENSITIVE MOLECULAR PROBES FOR MICROSCOPY OF CELLS AND TISSUESR01EB007276 · NIBIB · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2008 to 2011
$1.3M
FLUORESCENCE MOLECULAR TOMOGRAPHY SYSTEMS10OD020129 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2015
$330k
FLUORESCENCE LIFETIME IMAGING MICROSCOPY SYSTEMS10OD016237 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2014 to 2014
$267k
IVIS LUMINA II XR FOR OPTICAL IMAGING OF RADIOPHARMACEUTICALSS10RR031625 · NCRR · WASHINGTON UNIVERSITY · PI TAI, YUAN-CHUAN · 2011 to 2011
$218k
NCI NIH HHS P50 CA094056NCI NIH HHS R01 CA171651NCI NIH HHS U54 CA199092NCRR NIH HHS S10 RR031625NIBIB NIH HHS R01 EB007276NIBIB NIH HHS R01 EB008111NIH HHS S10 OD016237NIH HHS S10 OD020129
6 · The paper itself

Abstract

Similarity of skin cancer with many benign skin pathologies requires reliable methods to detect and differentiate the different types of these lesions. Previous studies have explored the use of disparate optical techniques to identify and estimate the invasive nature of melanoma and basal cell carcinoma with varying outcomes. Here, we used a concerted approach that provides complementary information for rapid screening and characterization of tumors, focusing on squamous cell carcinoma (SCC) of the skin. Assessment of in vivo autofluorescence lifetime (FLT) imaging of endogenous fluorophores that are excitable at longer wavelengths (480 nm) than conventional NADH and FAD revealed a decrease in the short FLT component for SCC compared to normal skin, with mean values of 0.57 ± 0.026 ?? ns and 0.61 ± 0.021 ?? ns , respectively ( p = 0.004 ). Subsequent systemic administration of a near-infrared fluorescent molecular probe in SCC bearing mice, followed by the implementation of image processing methods on data acquired from two-dimensional and three-dimensional fluorescence molecular imaging, allowed us to estimate the tumor volume and depth, as well as quantify the fluorescent probe in the tumor. The result suggests the involvement of lipofuscin-like lipopigments and riboflavin in SCC metabolism and serves as a model for staging SCC.

Indexed as

Fluorescent DyesAnimalsMiceMolecular ImagingSkin NeoplasmsFluorescent Dyes

Identifiers

PMID28613348
PMCPMC5470328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.